Objective: A review of amphetamine treatment for attention-deficit/hyperactivity disorder (ADHD) was conducted, to obtain information on the long-term neurological consequences of this therapy. Method: Several databases were accessed for research articles on the effects of amphetamine in the brain of laboratory animals and ADHD diagnosed individuals. Results: In early studies, high doses of amphetamine, comparable to amounts used by addicts, were shown to damage dopaminergic pathways. More recent studies, using therapeutic regimens, appear contradictory. One paradigm shows significant decreases in striatal dopamine and transporter density after oral administration of “therapeutic” doses in primates. Another shows morphological evidence of “trophic” dendritic growth in the brains of adult and juvenile rats given systemic injections mimicking “therapeutic” treatment. Imaging studies of ADHD-diagnosed individuals show an increase in striatal dopamine transporter availability that may be reduced by methylphenidate treatment. Conclusion: Clarification of the neurological consequences of chronic AMPH treatment for ADHD is needed. (J. of Att. Dis. 2007; 11(1) 8-16)
Barkley, R.A. , Fletcher, K. , Fischer, M. , & Smallish, L. (2003). Does the treatment of Attention Deficit/Hyperactivity Disorder with stimulants contribute to drug abuse? A 13-year prospective study . Pediatrics, 111, 97-109 .
2.
Bowyer, J.F. , Frame, L.T. , Clausing, P. , Nagamoto-Combs, K. , Osterhout, C.A. , Sterling, C.R. , et al. (1998). Long-term effects of amphetamine neurotoxicity on tyrosine hydroxylase mRNA and protein in aged rats . Journal of Pharmacology and Experimental Therapeutics, 286, 1074-1085 .
3.
Bradley, C. (1937). The behavior of children receiving Benzedrine . American Journal of Psychiatry, 94, 577-585 .
4.
Brown, G.L. , Hunt, R.D. , Ebert, M.H. , Bunney, W.E. Jr. , & Kopin, I.J. (1979). Plasma levels of d-amphetamine in hyperactive children . Psychopharmacology, 62, 133-140 .
5.
Connor, D.F. , & Steingard, R.J. (2004). New formulations of stimulants for attention-deficit hyperactivity disorder. CNSDrugs18, 1011-1030 .
6.
Ellison, G. , & Eison, M.S. (1983). Continuous amphetamine intoxication: An animal model of the acute psychotic episode . Psychological Medicine , 13, 751-761 .
7.
Ellison, G. , Eison, M.S. , Huberman, H.S. , & Daniel, F. (1978). Long-term changes in dopaminergic innervation of caudate nucleus after continuous amphetamine administration . Science, 201, 276-278 .
8.
Ellison, G. , & Ratan, R. (1982). The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism . Life Sciences, 31, 771-777 .
9.
Fone, K.C.F. , & Nutt, D.J. (2005). Stimulants: Use and abuse in the treatment of attention deficit hyperactivity disorder. Current Opinion in Pharmacology, 5, 87-93 .
10.
Fuller, R.W. (1985). Persistent effects of amphetamine, p-chloroamphetamine, and related compounds on central dopamine and serotonin neurons in rodents . Psychopharmacology Bulletin, 21, 528-532 .
11.
Fuller, R.W. , & Hemrick-Luecke, S. (1980). Long-lasting depletion of striatal dopamine by a single injection of amphetamine in iprindole-treated rats . Science, 209, 305-307 .
12.
Fuller, R.W. , & Hemrick-Luecke, S. (1982). Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine . Neuropharmacology, 21, 433-438 .
13.
Gibb, J.W. , Johnson, M. , Elayan, I. , Lim, H.K. , Matsuda, L. , & Hanson, G.R. (1999). Neurotoxicity of amphetamines and their metabolites . NIDA Research Monographs, 173, 128-145 .
14.
Greenhill, L.L. , Swanson, J.M. , Steinhoff, K. , Fried, J. , Posner, K. , Lerner, M. , et al. (2003). A pharmacokinetic/pharmacodynamic study comparing a single morning dose of Adderall to twice-daily dosing in children with ADHD . Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1234-1241 .
15.
Heijtz, R.D. , Kolb, B. , & Forssberg, H. (2003). Can a therapeutic dose of amphetamine during pre-adolescence modify the pattern of synaptic organization in the brain ? European Journal of Neuroscience, 18, 3394-3399 .
16.
Jonsson, G. , & Nwanze, E. (1982). Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse. BritishJournal of Pharmacology, 77, 335-345 .
17.
Karoum, F. , Speciale, S.G. Jr. , Chuang, L.-W. , & Wyatt, R.J. (1982). Selective effects of phenethylamine on central catecholamines: A comparative study with amphetamines . Journal of Pharmacology and Experimental Therapeutics, 223, 432-439 .
18.
Krause, J. , la Fougere, C. , Krause, K.-H. , Ackenheil, M. , & Dresel, S.H. (2005). Influence of striatal dopamine transporter availability on the response to methylphenidate in adult patients with ADHD . European Archives of Psychiatry and Clinical Neuroscience, 255, 428-431 .
19.
Kuczenski, R. , & Leith, N.J. (1981). Chronic amphetamine: Is dopamine a link in or a mediator of the development of tolerance and reverse tolerance? PharmacologyBiochemistry and Behavior, 15, 405-413 .
20.
Kuczenski, R. , & Segal, D. (1989). Concomitant characterization of behavioral and striatal neurotransmitter response to amphetamine using in vivo microdialysis . Journal of Neuroscience, 9, 2051-2065 .
21.
Lynch, M. , Kenny, M. , & Leonard, B.E. (1977). The effect of chronic administration of D-amphetamine on regional changes in catecholamines in the rat brain . Journal of Neuroscience Research, 3, 295-300 .
22.
Madras, B.K. , Miller, G.M. , & Fischman, A.J. (2005). The dopamine transporter and attention-deficit/hyperactivity disorder. BiologicalPsychiatry, 57, 1397-1409 .
23.
McCabe, S.E. , Knight, J.R. , Teter, C.J. , & Wechsler, H. (2005). Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey . Addiction, 99, 96-106 .
24.
McCann, U.D. , & Ricaurte, G.A. (2004). Amphetamine neurotoxicity: Accomplishments and remaining challenges . Neuroscience and Biobehavioral Reviews, 27, 821-826 .
25.
McCann, U.D. , Wong, D.F. , Yokoi, F. , Villemagne, V. , Dannals, R.F. , & Ricaurte, G.A. (1998). Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,482 . Journal of Neuroscience, 18, 8417-8422 .
26.
McGough, J.J. , Biederman, J. , Greenhill, L.L. , McCracken, J.T. , Spencer, T.J. , Posner, K. , et al. (2003). Pharmacokinetics of SLI381 (Adderall XR), an extended-release formulation of Adderall . Journal of the American Academy of Child and Adolescent Psychiatry, 42, 684-691 .
27.
Melega, W.P. , Quintana, J. , Raleigh, M.J. , Stout, D.B. , Yu, D.-C. , Lin, K.-P. , et al. (1996). 6-[18F]Fluoro-L-DOPA-PET studies show partial reversibility of long-term effects of chronic amphetamine in monkeys . Synapse, 22, 63-69 .
Melega, W.P. , Raleigh, M.J. , Stout, D.B. , Lacan, G. , Huang, S.-C. , & Phelps, M.E. (1997). Recovery of striatal dopamine function after acute amphetamine- and methamphetamine-induced neurotoxicity in the vervet monkey . Brain Research, 766, 113-120 .
30.
Molina, B.S.G. , & Pelham, W.E., Jr. (2003). Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD . Journal of Abnormal Psychology, 112, 497-507 .
31.
Moreira, C.Q. , Faria, M.J.S.S. , & Moreira, E. (2005). Behavioral neurotoxicity in adolescent and adult mice exposed to fenproporex during pregnancy . Human and Experimental Toxicology, 24, 403-408 .
32.
Nwanze, E. , & Jonsson, G. (1981). Amphetamine neurotoxicity on dopamine nerve terminals in the caudate nucleus of mice . Neuroscience Letters, 26, 163-168 .
Owen, F. , Baker, H.F. , Ridley, R.M. , Cross, A.J. , & Crow, T.J. (1981). Effects of chronic amphetamine administration on central dopaminergic mechanisms in the vervet . Psychopharmacology , 74, 213-216 .
35.
Pearl, R.G. , & Seiden, L.S. (1979). D-Amphetamine-induced increase in catecholamine synthesis in the corpus striatum of the rat: Persistence of the effect after tolerance . Journal of Neural Transmission, 44, 21-38 .
36.
Ricaurte, G.A. , Fuller, R.W. , Perry, K.W. , Seiden, L.S. , & Schuster, C.R. (1983). Fluoxetine increases long-lasting neostriatal dopamine depletion after administration of d-methamphetamine and d-amphetamine . Neuropharmacology, 22, 1165-1169 .
37.
Ricaurte, G.A. , Guillery, R.W. , Seiden, L.S. , & Schuster, C.R. (1984). Nerve terminal degeneration after a single injection of d-amphetamine in iprindole-treated rats: Relation to selective long-lasting dopamine depletion . Brain Research , 291, 378-382 .
38.
Ricaurte, G.A. , Guillery, R.W. , Seiden, L.S. , Schuster, C.R. , & Moore, R.Y. (1982). Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain . Brain Research, 235, 93-103 .
39.
Ricaurte, G.A. , Seiden, L.S. , & Schuster, C.R. (1984). Further evidence that amphetamines produce long-lasting dopamine neuro-chemical deficits by destroying dopamine nerve fibers . Brain Research, 303, 359-364 .
40.
Ricaurte, G.A. , Mechan, A.O. , Yuan, J. , Hatzidimitriou, G. , Xie, T. , Mayne, A.H. , et al. (2005). Amphetamine treatment similar to that used in the treatment of adult Attention Deficit/Hyperactivity Disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates . Journal of Pharmacology Experimental Therapeutics, 315, 91-98 .
41.
Ridley, R.M. , Baker, H.F. , Owen, F. , Cross, A.J. , & Crow, T.J. (1982). Behavioral and biochemical effects of chronic amphetamine treatment in the vervet monkey . Psychopharmacology , 78, 245-251 .
42.
Robinson, T.E. , & Becker, J.B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis . Brain Research Review, 11, 157-198 .
43.
Robinson, T.E. , & Camp, D.M. (1987). Long-lasting effects of escalating doses of d-amphetamine on brain monoamines, amphetamine-induced stereotyped behavior and spontaneous nocturnal locomotion. PharmacologyBiochemistry and Behavior , 26, 821-827 .
44.
Robinson, T.E. , & Kolb, R. (1997). Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine . Journal of Neuroscience, 17, 8491-8497 .
45.
Robinson, T.E. , & Kolb, B. (1999). Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine . European Journal of Neuroscience, 11, 1598-1604 .
46.
Ryan, L.J. , Linder, J.C. , Martone, M.E. , & Groves, P.M. (1990). Histological and ultrastructural evidence that d-amphetamine causes degeneration in neostriatum and frontal cortex of rats . Brain Research, 518, 67-77 .
47.
Ryan, L.J. , Martone, M.E. , Linder, J.C. , & Groves, P.M. (1988). Continuous amphetamine administration induces tyrosine hydroxylase immunoreactive patches in the adult rat neostriatum . Brain Research Bulletin, 21, 133-137 .
48.
Schiffer, W.K. , Volkow, N.D. , Fowler, J.S. , Alexoff, D.L. , Logan, J. , & Dewey, S.L. (2006). Therapeutic doses of amphetamine or methylphenidate differentially increase synaptic and extracellular dopamine . Synapse, 59, 243-251 .
49.
Seiden, L.S. , & Sabol, K.E. (1996). Methamphetamine and methylenedioxymethamphetamine neurotoxicity: Possible mechanisms of cell destruction . NIDA Research Monograph , 163, 251-276 . Solanto, M.V. (2000). Clinical psychopharmacology of AD/HD: Implications for animal models . Neuroscience and Biobehavioral Reviews, 24, 27-30 .
50.
Sonsalla, P.K. , Jochnowitz, N.D. , Zeevalk, G.D. , Postveen, J.A. , & Hall, E.D. (1996). Treatment of mice with methamphetamine produces cell loss in the substantia nigra . Brain Research, 738, 172-175 .
51.
Spencer, T.J. , Biederman, J. , Madras, B.K. , Faraone, S.V. , Dougherty, D.D. , Bonab, A.A. , et al. (2005). In vivo neuroreceptor imaging in Attention-Deficit/Hyperactivity Disorder: A focus on the dopamine transporter. BiologicalPsychiatry, 57, 1293-1300 .
52.
Steranka, L.R. (1981). Stereospecific long-term effects of amphetamine on striatal dopamine neurons in rats. EuropeanJournal of Pharmacology, 76, 443-446 .
53.
Steranka, L.R. (1983). Long-term effects of a priming dose and short-term infusion of amphetamine on striatal dopamine neurons in rats. EuropeanJournal of Pharmacology, 96, 159-163 .
54.
Steranka, L.R. , & Sanders-Bush, E. (1980). Long-term effects of continuous exposure to amphetamine on brain dopamine concentration and synaptosomal uptake in mice. EuropeanJournal of Pharmacology, 65, 439-443 .
55.
Swanson, J.M. , Cantwell, D. , Lerner, M. , McBurnett, K. , & Hana, G. (1991). Effects of stimulant medication on learning in children with ADHD. Journal ofLearning Disorders, 24, 219-255 .
56.
Tan, S.E. (2003). Prenatal amphetamine exposure alters behavioral reactivity to amphetamine in rats. Neurotoxicology andTeratology , 25, 579-585 .
57.
Teter, C.J. , McCabe, S.E. , Cranford, J.A. , Boyd, C.J. , & Guthrie, S.K. (2005). Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample . Journal of the American College of Health,53, 253-262 .
58.
Thompson, P.M. , Hayashi, K.M. , Simon, S.L. , Geaga, J.A. , Hong, M.S. , Sui, Y. , et al. (2004). Structural abnormalities in the brains of human subjects who use amphetamine . Journal of Neuroscience , 24, 6028-6036 .
59.
Villemagne, V. , Yuan, J. , Wong, D.F. , Dannals, R.F. , Hatzidimitriou, G. , Mathews, W.B. et al. (1998). Brain dopamine neurotoxicity in baboons treated with doses of methamphetamine comparable to those recreationally abused by humans: Evidence from [11C]WIN-35,428 positron emission tomography studies and direct in vitro determinations . Journal of Neuroscience , 18, 419-427 .
60.
Vitiello, B. (2001). Long-term effects of stimulant medications on the brain: Possible relevance to the treatment of Attention Deficit Hyperactivity Disorder . Journal of Child and Adolescent Psychopharmacology , 11, 25-34 .
61.
Volkow, N.D. , Chang, L. , Wang, G.J. , Fowler, J.S. , Leonido-Yee, M. , Franceschi, D. et al. (2001). Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers . American Journal of Psychiatry, 158, 377-382 .
62.
Volkow, N.D. , & Insel, T.R. (2003). What are the long-term effects of methylphenidate treatment? BiologicalPsychiatry, 54, 1307-1309 .
63.
Volkow, N.D. , & Swanson, J.M. (2003). Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD . American Journal of Psychiatry, 160, 1909-1918 .
64.
Volkow, N.D. , Wang, G.-J. , Fowler, J.S. , & Ding, Y.S. (2005). Imaging the effects of methylphenidate on brain dopamine: New model on its therapeutic actions for Attention-Deficit/Hyperactivity Disorder. BiologicalPsychiatry, 57, 1410-1415 .
65.
Wagner, G.C. , Ricaurte, G.A. , Johanson, C.E. , Schuster, C.R. , & Seiden, L.S. (1980). Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate . Neurology, 30, 547-550 .
66.
Wilens, T.E. (2003). Drug therapy for adults with Attention-Deficit Hyperactivity Disorder . Drugs, 63, 2395-2411 .
67.
Wilens, T.E. , Faraone, S.V. , & Biederman, J. (2004). Attention-Deficit/Hyperactivity Disorder in adults . Journal of the American Medical Association,292, 619-623 .
68.
Wilens, T.E. , Faraone, S.V. , Biederman, J. , & Gunawardene, S. (2003). Does stimulant therapy of Attention-Deficit/Hyperactivity Disorder beget later substance abuse? A meta-analytic review of the literature . Pediatrics, 111, 179-185 .
69.
Woolverton, W.L. , Ricaurte, G.A. , Forno, L.S. , & Seiden, L.S. (1989). Long-term effects of chronic methamphetamine administration in rhesus monkeys . Brain Research, 486, 73-78 .
70.
Yuan, J. , McCann, U. , & Ricaurte, G. (1997). Methylphenidate and brain dopamine neurotoxicity . Brain Research, 767, 172-175 .
71.
Zaczek, R. , Battaglia, G. , Contrera, J.F. , Culp, S. , & De Souza, E.B. (1989). Methylphenidate and pemoline do not cause depletion of rat brain monoamine markers similar to that observed with methamphetamine . Toxicology and Applied Pharmacology , 100, 227-233 .
